Adynxx (FRA:HL1C) Change In Payables And Accrued Expense : €1.30 Mil (TTM As of Sep. 2019)

View and export this data going back to 1998. Start your Free Trial

What is Adynxx Change In Payables And Accrued Expense?

Adynxx's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2019 was €1.31 Mil. It means Adynxx's Accounts Payable & Accrued Expense increased by €1.31 Mil from Jun. 2019 to Sep. 2019 .

Adynxx's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2018 was €-3.30 Mil. It means Adynxx's Accounts Payable & Accrued Expense declined by €3.30 Mil from Dec. 2017 to Dec. 2018 .

Adynxx Change In Payables And Accrued Expense Historical Data

The historical data trend for Adynxx's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adynxx Change In Payables And Accrued Expense Chart

Adynxx Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

1.43

-0.06

2.52

-1.38

-3.30

Adynxx Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.10	-1.54	-0.47	2.01	1.31

Adynxx Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.30 Mil.

Adynxx Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Adynxx's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Adynxx (FRA:HL1C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adynxx Inc (FRA:HL1C) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Pine Street, Suite 500, San Francisco, CA, USA, 94111

Website

http://www.adynxx.com

Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.

Adynxx (FRA:HL1C) Headlines

No Headlines